ELISA in Relapsed/Refractory MM

NCT06832865 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Refractory Multiple Myeloma (RRMM)
Relapsed Refractory Multiple Myeloma

Interventions

DRUG: elranatamab
DRUG: Isatuximab SC
DEVICE: Isatuximab SC-OBDS

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]